Genefitletics, a biotech company founded in 2019, uses system biology & mathematics to accelerate the speed at which application of scientific discoveries & molecular data driven personalization empowers people to reclaim control of their health
Harnessing the power of next generation sequencing, cloud computing & machine learning, Genefitleticss system biology platform measures & analyzes biology & chemistry of an individual at molecular level to deeply understand origin & progression of chronic diseases in order to prevent, diagnose them early, stop their progression and reverse them.
This data driven platform that precisely characterize human-microbial interactions :
1)Provide patients with unique molecular insights & precision nutrition interventions to bring their body back into homeostasis
2)Give healthcare practitioners access to hard to detect pre disease signals which conventional clinical diagnostic tests cannot identify, enabling them to align their interventions with patient’s unique biochemical individuality
The company is led by a team of researchers, inventors, industry experts & passionate & curious entrepreneurs with a combined leadership & executive experience of 30 + years who are on a journey to impact human health.
The company has been awarded as :
1) Best chronic illness prevention R &D Biotech company 2024-South Asia by Global Health & Pharma
2)Biotech Innovation Excellence Award 2024- by Global Heath & Pharma
3)Microbiome Therapeutics as a service platform, 2023 by AWS & MINFY in association with CNBC
4)Chronic Illness Prevention R&D Biotech Company- Asia,2022 by Global Health Pharma
5)Specialist Biotech Company of the year, CorporateLiveWire, Global Awards, 2022/23
6) Microbiome Therapeutics as a service platform, 2023 by Global Health & Pharma
7) Chronic Illness Prevention R&D Biotech Company of the Year 2023 - Asia by AI Global Media
